PARP 抑制剂与 HRD 诱导分子靶向剂的合理组合。
关键词: AKT pathway AXL inhibition Angiogenesis BET inhibition GAS6 HDAC inhibition Hsp90 inhibition MAPK pathway MEK inhibition PI3K mTOR
Mesh : Female Humans Poly(ADP-ribose) Polymerase Inhibitors / pharmacology therapeutic use Ovarian Neoplasms Antineoplastic Agents / therapeutic use Homologous Recombination
来 源: DOI:10.1007/978-3-031-30065-3_10